426
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Looking back and going forward: what should the new European Commission do in order to promote evidence-based policy-making?

&
Pages 1359-1378 | Received 07 Mar 2016, Accepted 10 Apr 2016, Published online: 26 May 2016

References

  • Alemanno, A. 2010. The Fabulous Destiny of Bisphenol A: The Latest EU and WHO Moves. November 30, 2010. (Alemanno’s home page).
  • Alemanno, A. 2011. Ban on Bisphenol A in Baby Bottles in the European Union as of Today (Alemanno’s home page).
  • Alemanno, A. 2013a. Moment of Truth for Bisphenol A in the EU. April 3, 2013 (Alemanno’s home page).
  • Alemanno, A. 2013b. “The Science, Law and Policy of Neonicotinoids and Bees: A New Test Case for the Precautionary Principle.” European Journal of Risk Regulation 4: 191–207.
  • Alemanno, A. 2014. “What Role-If Any-for a Chief Scientist in the European Union System for Scientific Advice.” European Journal of Risk Regulation 5: 286–292.
  • Autrup, H., F. Barile, B. Blauboer, G. Degen, W. Dekant, D. Dietrich, J. Domingo et al. 2015. “Principles of Pharmacology and Toxicology also Govern Effects of Chemicals on the Endocrine System.” Toxicological Sciences 146: 11–15.
  • Ball, C. 2004. “What is Transparency?” Public Integrity 11: 293–307.
  • Ballantine, B. 2005. Enhancing the Role of Science in the Decision Making of the European Union. Brussels: European Policy Centre.
  • Bonefeld-Jørgensen, E., M. Long, M. Hofmeister, and A. Vinggaard. 2007. “Endocrine-Disrupting Potential of Bisphenol A, Bisphenol A Dimethacrylate, 4-N-Nonylphenol, and 4-N-Octylphenol in Vitro: New Data and a Brief Review.” Environmental Health Perspectives 115 (S-1): 69–76.10.1289/ehp.9368
  • Bouder, F., D. Way, R. Lofstedt, and D. Evensen. 2015. “Transparency in Europe: A Quantitative Study.” Risk Analysis. 35: 1210–1229
  • Braun, J., and R. Hauser. 2011. “Bisphenol A and Childrenʼs Health.” Current Opinion in Pediatrics 23: 233–239.10.1097/MOP.0b013e3283445675
  • Breakwell, G. 2007. The Psychology of Risk. Cambridge: Cambridge University Press.10.1017/CBO9780511819315
  • Butterworth, T. 2009. Science Suppressed: How America Became Obsessed with BPA. Washington, DC: George Mason University’s Center for Health and Risk Communication.
  • CEO. 2014. Open Letter: The Position of the Chief Scientific Adviser to the President of the European Commission. 22nd July. Brussels: Corporate European Observatory.
  • Christoferou, T. 2003. “The Precautionary Principle in European Community Law and Science.” In Precaution, Environmental Science and Preventive Public Policy, edited by J. Tickner, 241–262. Washington, DC: Island Press.
  • Coglianese, C. 2009. “The Transparency President? The Obama Administration and Open Government.” Governance 22: 529–544.10.1111/gove.2009.22.issue-4
  • Coglianese, C., H. Kilmartin, and E. Mendelson. 2008. Transparency and the Public Participation in the Rulemaking Process: A Non-partisan Presidential Task Force Report. Philadelphia: University of Pennsylvania Law School.
  • Corporate European Observatory. 2012. Conflicts on the Menu: A Decade of Industry Influence at the European Food Safety Authority. Brussels: CEO.
  • Dalli, J. 2011. Pharmaceuticals: Today, the EU Register of Clinical Trials is launched online. 22nd March. Brussels: DG SANCO.
  • Dunlop, C., and C. Radaelli. 2015. “Impact Assessment in the European Union: Lessons from a Research Project.” European Journal of Risk Regulation 6: 27–34.
  • Economist. 2014. The Battle of Scientists-Are Europeans Becoming More Hostile to Science and Technology? December 20.
  • EurActiv. 2013. Chief EU Scientist Backs Damming Report Urging GMO ‘Rethink’. Brussels: EurActiv, September 26.
  • EurActiv. 2014a. Sweden to Sue the Commission for Delaying Hormone-Affecting Criteria. Brussels: EurActiv, February 26.
  • EurActiv. 2014b. EU’s Revamped Industrial Policy Dogged by ‘Better Regulation’ Dispute. Brussels: EurActiv, November 28.
  • EurActiv. 2015. EU’s Food Safety Agency Gives Green Light to Bisphenol A. Accessed January 21, 2015. http://www.euractiv.com/sections/agriculture-food/eus-food-safety-agency-gives-green-light-bisphenol-311445
  • EC (European Commission). 2000. Communication from the Commission on the Precautionary Principle. Brussels: European Commission (COM 2000-1 Final).
  • EC (European Commission). 2007. Commission Communication Responding to Strategic Needs: Reinforcing the Use of Evaluation. Brussels: European Commission SEC 213.
  • EC (European Commission). 2015a. Communication from Commission “Better Regulation for Better Results-an EU Agenda. Brussels: European Commission (COM 2015-215 Final).
  • EC (European Commission). 2015b. Press Release: President Juncker Welcomes World-leading Scientists, Discusses Role of Science in Competitiveness and Announces New Mechanism for Scientific Advice. Brussels: European Commission, May 13.
  • EC (European Commission). 2013. Commission Communication “Strengthening the foundations of Smart Regulation-improving evaluation.” Brussels: European Commission (COM 2013-686 Final).
  • EC (European Commission). 2014. Commission Communication “Regulatory Fitness and Performance Programme (REFIT): State of play and outlook.” Brussels: European Commission (COM 2014-368 Final).
  • EC (European Commission). 2010. Cited in BBC News: EU Bans Bisphenol A Chemical from Babies’ Bottles. BBC News. Accessed November 26, 2010. http://www.bbc.co.uk/news/world-europe-11843820.
  • EFSA (European Food Safety Authority). 2008. “Scientific Opinion of the Panel on Food Additives, Flavourings, Processing Aids, and Materials in Contact with Food (AFC) Related to Toxicokinetics of Bisphenol A.” EFSA Journal 759: 1–10.
  • EFSA (European Food Safety Authority). 2010. “Scientific Opinion on Bisphenol A: Evaluation of a Study Investigating Its Neurodevelopmental Toxicity, Review of Recent Scientific Literature on Its Toxicity and Advice on the Danish Risk Assessment of Bisphenol A.” EFSA Journal 8 (9): 1829–1945. http://www.efsa.europa.eu/en/efsajournal/pub/1829.
  • EFSA (European Food Safety Authority) (2013). “EFSA Supports European Commission in Defining Scientific Criteria for Endocrine Disruptors.” Press Release. Accessed March 20, 2013. http://www.efsa.europa.eu/en/press/news/130320
  • EFSA (European Food Safety Authority). 2014. Transformation to an Open EFSA. Parma: EFSA.
  • EFSA (European Food Safety Authority). 2015. No Consumer Health Risk from Bisphenol A Exposure. Press Release, January 21, 2015. http://www.efsa.europa.eu/en/press/news/150121.
  • HOA (European Heads of Agency). 2012. “Heads of National Food Agencies Working Group on Transparent Use of Risk Assessment in Decision Making.” Final Report to the Heads of Agencies, April 2012. http://www.food.gov.uk/sites/default/files/multimedia/pdfs/decision-making-docs.pdf.
  • European Medicines Agency. 2014. Publication of Clinical Reports: EMA Adopts Landmark Policy to Take Effect on 1st January 2015. EMA/601455/2104. London: EMA.
  • Fisher, E. 2007. Risk: Regulation and Administrative Constitutionalism. Oxford: Hart Publishing.
  • Fisher, E. 2010. “New Regulatory Concepts and the Law.” In Risk and Regulatory Policy: Improving the Governance of Risk, edited by OECD, 45–92, Paris: OECD.
  • Florini, A. 1999. “Does the Invisible Hand Need a Transparent Glove? The Politics of Transparency.” Paper in the Annual World Bank Conference on Development Economics. Washington, DC.
  • FAO (Food and Agriculture Organisation) and WHO (World Health Organisation). 2010. Joint FAO/WHO Expert Meeting to Review Toxicological and Health Aspects of Bisphenol A. November 2010. Ottawa: FAO/WHO.
  • Graham, J. D. 2001. “Decision-analytic Refinements of the Precautionary Principle.” Journal of Risk Research 4: 127–142.
  • Graham, J. D. 2010. “Why Governments need Guidelines for Risk Assessment and Management.” In OECD Review of Regulatory Reform-Risk and Regulatory Policy: Improving the Governance of Risk, edited by OECD, 237–247. Paris: OECD.
  • Girling, J. 2013. “Commentary on Lofstedt Working Group Paper.” Risk Analysis 33: 1188–1189.
  • Girling, J. 2014. “The Role of Science in the 21st Century EU Policy Making.” European Journal of Risk Regulation 5: 300–302.
  • Glover, A. 2014. 1000 days in the Life of a Chief Scientific Adviser. Auckland, New Zealand, 28th August.
  • Glover, A. 2015a. “Anne Glover on Brussels: A moment of magic realism in the European Commission.” The Guardian, February 5.
  • Glover, A. 2015b. “Greenpeace hypocritical, says ousted EU scientist.” The Times, February 7.
  • Goodman, Julie E., E. McConnell, I. Sipes, R. Witorsch, T. Slayton, C. Yu, A. Lewis, and L. Rhomberg. 2006. “An Updated Weight of the Evidence Evaluation of Reproductive and Developmental Effects of Low Doses of Bisphenol A.” Critical Reviews in Toxicology 36: 387–457.10.1080/10408440600758317
  • Gray, G., J. Cohen, G. Cunha, C. Hughes, E. McConnell, L. Rhomberg, I. Sipes, and D. Mattison. 2004. “Weight of the Evidence Evaluation of Low-Dose Reproductive and Developmental Effects of Bisphenol A.” Human and Ecological Risk Assessment: An International Journal 10: 875–921.10.1080/10807030490513883
  • Gray, L. E., B. Ryan, A. Hotchkiss, and K. Crofton. 2010. “Rebuttal of “Flawed Experimental Design Reveals the Need for Guidelines Requiring Appropriate Positive Controls in Endocrine Disruption Research” by Vom Saal.” Toxicological Sciences 115: 614–620.10.1093/toxsci/kfq073
  • Heald, D. 2006. “Varieties of Transparency.” In Transparency: The Key to Better Governance? edited by C. Hood and D. Heald, 25–43. London: Proceedings of the British Academy.
  • Health Canada. 2008. Government of Canada Protects Families with Bisphenol A Regulations. Ottawa: Health Canada, October 17, 2008.
  • Lakind, J., M. Goodman, and D. Naiman. 2012. “Use of NHANES Data to Link Chemical Exposures to Chronic Diseases: A Cautionary Tale.” PLoS ONE 1: 712e51086. 10.1371/journal.pone.0051086. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515548/.
  • Lee, S., J. Kim, J. Chung, Y. Kim, J. Park, S. Oh, Y. Yoon, K. Yoo, Y. Yoo, and J. Kim. 2013. “Bisphenol A Exposure during Adulthood Causes Augmentation of Follicular Atresia and Luteal Regression by Decreasing 17β-Estradiol Synthesis via Downregulation of Aromatase in Rat Ovary.” Environmental Health Perspectives 121: 663–669. doi:10.1289/ehp.1205823.
  • Löfstedt, R. E. 2004. “The Swing of the Regulatory Pendulum in Europe: From Precautionary Principle to (Regulatory) Impact Analysis.” Journal of Risk and Uncertainty 28: 237–260.10.1023/B:RISK.0000026097.72268.8d
  • Löfstedt, R. 2005. Risk Management in Post-Trust Societies. Basingstoke: Palgrave/MacMillan.10.1057/9780230503946
  • Lofstedt, R. 2010. “Risk Communication Guidelines for Europe: A Modest Proposition.” Journal of Risk Research 13: 87–109.10.1080/13669870903126176
  • Lofstedt, R. E. 2011a. “Risk versus Hazard: How to Regulate in the 21st Century.” European Journal of Risk Regulation 2: 149–168.
  • Lofstedt, R. 2011b. Reclaiming Health and Safety for all: An Independent Review of Health and Safety Legislation. London: Department of Work and Pensions.
  • Lofstedt, R. 2013a. “Communicating Food Risks in an Era of Growing Public Distrust: Three Case Studies.” Risk Analysis 33 (2): 192–202.10.1111/risk.2013.33.issue-2
  • Lofstedt, R. E. 2013b. “The Informal European Parliamentary Working Group on Risk-History, Remit, and Future Plans: A Personal View.” Risk Analysis 33: 1182–1187.10.1111/risa.2013.33.issue-7
  • Lofstedt, R. E. 2014a. “Chemical Control Policy in Sweden, What is Next?” European Journal of Risk Regulation 5: 351–358.
  • Lofstedt, R. E. 2014b. “The Precautionary Principle in the EU: Why a Formal Review is Long Overdue.” Risk Management 16: 137–163.10.1057/rm.2014.7
  • Lofstedt, R., and F. Bouder. 2014. “New Transparency Policies: Risk Communication’s Doom?” In Effective Risk Communication, edited by J. Arvai and L. Rivers, 73–90. London: Earthscan.
  • Majone, G., and M. Everson. 2001. “Institutional Reform: Independent Agencies, Oversight, Coordination and Procedural Control.” In Governance in the European Union, edited by O. DeSchutter, N. Lebessis and J. Paterson, 129–168. Luxembourg: Office for the Official Publications of the European Communities.
  • Marchant, G., L. Abbott, A. Felsot, and R. Griffin. 2013. Impact of the Precautionary Principle on Feeding Current and Future Generations. Washington, DC: US Department of Agriculture, CAST issue paper no. 52.
  • Meijer, A. 2009. “Understanding Modern Transparency.” International Review of Administrative Sciences 75: 255–269.10.1177/0020852309104175
  • Melzer, D., N. Rice, C. Lewis, W. Henley, and T. Galloway. 2010. “Association of Urinary Bisphenol A Concentration with Heart Disease: Evidence from NHANES 2003/06.” PLoS ONE 5 (1): e8673.10.1371/journal.pone.0008673
  • Nagel, S C, F. vom Saal, K. Thayer, M. Dhar, and M Boechler. 1997. “Relative Binding Affinity-Serum Modified Access (RBA-SMA) Assay Predicts the Relative in Vivo Bioactivity of the Xenoestrogens Bisphenol A and Octylphenol.” Environmental Health Perspectives 105: 70–76.10.1289/ehp.9710570
  • Norris, P. 2001. Digital Divide. Cambridge: Cambridge University Press.10.1017/CBO9781139164887
  • Paterson, O. 2013. Speech on the Benefits of Genetically Modified Crops. June 21.
  • Paterson, O. 2014. Growing Voices: Health Food-the Untold Story of GM Crops. January 24.
  • Paterson, O. 2015. Speech: Annual South African Agricultural Biotechnology Industry ISAAA Media Conference, Pretoria, South Africa, February 24.
  • Pollack, M., and G. Shaffer. 2009. When Cooperation Fails. Oxford: Oxford University Press.10.1093/acprof:oso/9780199237289.001.0001
  • Pollit, C., and G. Bouckaert. 2011. Public Management Reform: A Comparative Analysis. Oxford: Oxford University Press.
  • Pott, A. 2015. Your own initiative inquiry OI/3/2014 (BEH)FOR.EMA/55447/2015. London: EMA.
  • Rasi, G. 2013. “Clinical Data: Time for a New Approach.” Financial Times, April 30, p. 10.
  • Renda, A. 2006. Impact Assessment in the EU: The State of the Art and the Art of the State. Brussels: Centre for European Policy Studies.
  • Renda, A., L. Schrefler, G. Luchestta, and R. Zavatta. 2013. Analysing the Costs and Benefits of Regulation: Study for the European Commission, Secretariat General. Brussels: Centre for European Policy Studies.
  • Richter, C., L. Birnbaum, F. Farabollini, R. Newbold, B. Rubin, C. Talsness, J. Vandenberg, D. Walser-Kuntz, and F. vom Saal. 2007. “In Vivo Effects of Bisphenol A in Laboratory Rodent Studies.” Reproductive Toxicology 24: 199–224.10.1016/j.reprotox.2007.06.004
  • Robinson, C., N. Holland, D. Leloup, and H. Muilerman. 2013. “Conflicts of Interest at the European Food Safety Authority Erode Public Confidence.” Journal of Epidemiology Community Health 67: 717–720. doi:10.1136/jech-2012-202185.
  • Rochester, J. 2013. “Bisphenol A and Human Health: A Review of the Literature.” Reproductive Toxicology 42: 132–155.10.1016/j.reprotox.2013.08.008
  • vom Saal, F., B. Akingbemi, S. Belcher, L. Birnbaum, D. Crain, M. Eriksen, F. Farabollini, et al. 2007. “Chapel Hill Bisphenol A Expert Panel Consensus Statement: Integration of Mechanisms, Effects in Animals and Potential to Impact Human Health at Current Levels of Exposure.” Reproductive Toxicology 24: 131–138.10.1016/j.reprotox.2007.07.005
  • vom Saal, F., and C. Hughes. 2005. “An Extensive New Literature concerning Low-Dose Effects of Bisphenol A Shows the Need for a New Risk Assessment.” Environmental Health Perspectives 113: 926–933.10.1289/ehp.7713
  • Schultz, H., and P. Wiedemann. 2000. “Hazardous Incident Information for the Public: Is It Useful?” Australiasian Journal of Disaster and Trauma Studies 2000 (2): 1174–xxxx.
  • Sharpe, R. 2010. “Is It Time to End Concerns over the Estrogenic Effects of Bisphenol A?” Toxicological Sciences 114: 1–4.10.1093/toxsci/kfp299
  • Smismans, S. 2015. “Policy Evaluation in the EY: The Challenges of Linking Ex Ante and Ex Post Appraisal.” European Journal of Risk Regulation 6: 6–26.
  • Swedish Chemicals Agency. 2015. Arsredovisning 2014. Sundbyberg: Swedish Chemicals Agency. (annual report 2014).
  • Swedish Ministry of the Environment. 2013. Pa vag mot en giftfri vardag-platform for kemikaliepolitiken [Toward Non-toxic Living: A Platform for Chemical Policy]. Stockholm: Swedish Ministry of the Environment.
  • Teeguarden, J., and S. Hanson-Drury. 2013. “A Systematic Review of Bisphenol A “Low Dose” Studies in the Context of Human Exposure: A Case for Establishing Standards for Reporting “Low-Dose” Effects of Chemicals.” Food and Chemical Toxicology 62: 935–948.10.1016/j.fct.2013.07.007
  • The Endocrine Society. 2009. “Endocrine-Disrupting Chemicals.” Position Statement, June 2009. Maryland: The Endocrine Society.
  • Timmermans, F. 2015. Better Regulation Agenda: Enhancing Transparency and Scrutiny for Better EU Law Making-Press Release. Brussels: European Commission, 19th May.
  • UK Department of Business Innovation and Skills. 2013. Cut EU Red Tape: Report from the Business Taskforce. London: BIS.
  • Vandenberg, L., I. Chahoud, J. Heindel, V. Padmanabhan, F. Paumgartten, and G. Schoenfelder. 2010. “Urinary, Circulating, and Tissue Biomonitoring Studies Indicate Widespread Exposure to Bisphenol A.” Environmental Health Perspectives 118 (8): 1055–1070.10.1289/ehp.0901716
  • Vogel, S. 2009. “The Politics of Plastics: The Making and Unmaking of Bisphenol A “Safety”.” American Journal of Public Health 99: S559–S566.10.2105/AJPH.2008.159228
  • Vogel, D. 2012. The Politics of Precaution: Regulating Health, Safety, and Environmental Risks in Europe and the United States. Princeton: Princeton University Press.
  • Wall Street Journal. 2014. Juncker Science, December 2, p. 13.
  • Wang, F., J. Hua, M. Chen, Y. Xia, Q. Zhang, R. Zhao, W. Zhou, Z. Zhang and B. Wang. 2012. “High Urinary Bisphenol A Concentrations in Workers and Possible Laboratory Abnormalities.” Occupational and Environmental Medicine 69: 679–684. Published online May 5, 2012. doi:10.1136/oemed-2011-100529.
  • Wallstrom, M. 2002. EU and US approaches to environmental policy. Speech given at the European Institute, Washington DC, April 25.
  • Way, D., and R. Lofstedt. 2015. When is transparency satisfied? Comparing transparency policies at the European Medicines Agency (EMA) and the European Food Safety Authority (EFSA). Article is under peer review.
  • Wemmert, L., and M. Karlsson. 2013. “Sverige bor folja Frankrike och forbjuda bisfenol A [Sweden should follow France and ban Bisphenol A].” Svenska Dagbladet, January 17.
  • Westlund, A. 2013. Compromise Amendments: Protection of Public Health from Endocrine Disrupters. Brussels: European Parliament.
  • Wiener, J. 2010. “Risk Regulation and Governance Institutions.” In OECD Reviews of Regulatory Reform-Risk and Regulatory Policy: Improving the Governance of Risk, edited by OECD, 133–157. Paris: OECD.
  • Whitworth, J. 2015. “EU Commission urged to act on French BPA ban.” Food Quality News, February 5.
  • Wilsdon, J. 2014. “The Past, Present and Future of the Chief Scientific Advisor.” European Journal of Risk Regulation 5: 293–299.
  • WHO (World Health Organisation). 2012. State of the Science of Endocrine Disrupting Chemicals 2012. World Health Organisation. ISBN: 978 92 4 150503 1 (WHO). www.who.int/iris/bitstream/10665/78101/1/9789241505031.
  • Zander, J. 2010. The Application of the Precautionary Principle in Practice: Comparative Dimensions. Cambridge: Cambridge University Press.
  • Zoeller, R., A. Bergman, G. Becher, P. Bjerregaard, R. Bornman, I. Brandt, T. Iguchi, et al. 2014. “A Path forward over Health Impacts of Endocrine Disrupting Chemicals.” Environmental Health 14: 118.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.